UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059027
Receipt number R000067511
Scientific Title Analysis of Factors Associated with ADL Improvement and Rehabilitation Efficacy in Patients Admitted to a Convalescent Rehabilitation Ward: A Retrospective Observational Study
Date of disclosure of the study information 2025/09/08
Last modified on 2025/09/08 12:16:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of Various Factors and Evaluation of Rehabilitation Outcomes in Inpatients of a Rehabilitation Ward

Acronym

Evaluation of Rehabilitation Outcomes for Hospitalized Rehabilitation Patients

Scientific Title

Analysis of Factors Associated with ADL Improvement and Rehabilitation Efficacy in Patients Admitted to a Convalescent Rehabilitation Ward: A Retrospective Observational Study

Scientific Title:Acronym

Analysis of Factors for ADL in Rehabilitation - Convalescent Rehabilitation Ward

Region

Japan


Condition

Condition

cerebrovascular disease, musculoskeletal disorders, disuse syndrome, etc.

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The first objective of this study is factor analysis, with a primary focus on outcome prediction. By analyzing the progress of physical function and Activities of Daily Living (ADL) in patients admitted to a convalescent rehabilitation ward (CRW), we aim to improve the accuracy of outcome predictions and to clarify the relationships between various factors for clinical application.

The second objective is to evaluate the effectiveness of our treatments and various clinical interventions.

The third objective is to investigate and organize incident and near-miss reports within the CRW to identify problems and develop countermeasures. In particular, the analysis of near-miss reports could be a valuable contribution, as this has been seldom reported in previous studies.

We believe the findings of these analyses will be significant, as they will be applied to the care of future inpatients.

Basic objectives2

Others

Basic objectives -Others

Elucidating the consequences of ADL by disease

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

a. Basic Information

* Age
* Primary disease
* Past medical history
* Date of onset
* Dates of admission and discharge
* Duration of therapy/training
* Brain imaging data
* X-ray imaging data
* Motor ability
* Video data
* Level of consciousness
* Nutritional status
* Information on social resources
* Orthoses and assistive devices used
* Problem list
* Standardized tasks, etc.


b. Information Based on Assessments


b-1. Assessment of Physical Function

* Fugl-Meyer Assessment (FMA)
* American Spinal Injury Association (ASIA) Impairment Scale
* Frankel Classification
* Muscle strength
* Range of Motion (ROM) assessment, etc.

b-2. Assessment of Functional Ability

* Functional Independence Measure (FIM)
* Spatiotemporal gait parameters (e.g., velocity, cadence, stride, step count)
* Functional Ambulation Categories (FAC)
* Gait Ability Assessment for Hemiplegics (GAA) and other gait ability assessments
* Standard Test for Aphasia and Dysarthria (STAD)
* Independence checklist, etc.

Key secondary outcomes

b-3. Assessment of Higher Brain Function

* Hasegawa's Dementia Scale-Revised (HDS-R)
* Mini-Mental State Examination (MMSE)
* Frontal Assessment Battery (FAB)
* Trail Making Test (TMT)
* Kohs Block Design Test (KBDT)
* Cognitive-related Behavioral Assessment (CBA)
* Raven's Colored Progressive Matrices (RCPM), etc.

b-4. Assessment for Aphasia

* Standard Language Test of Aphasia (SLTA)
* Communication effectiveness scales, etc.

b-5. Assessment for Dysarthria

* Assessment of Motor Speech for Dysarthria (AMSD)
* Auditory-perceptual evaluation of hoarseness (GRBAS scale)
* Sound pressure level measurement (e.g., maximum phonation, coughing, conversation)
* Speech intelligibility assessment, etc.

b-6. Assessment for Dysphagia

* Original Inoue-Evaluation for Aspiration Lung Disease (i-EALD)
* Sound pressure level measurement (e.g., maximum phonation, coughing, conversation)
* Oral Health Assessment Tool (OHAT)
* Repetitive Saliva Swallowing Test (RSST)
* Modified Water Swallowing Test (MWST)
* Fujishima's Ingestive and Swallowing ability Scale (FILS)
* Dysphagia Severity Scale (DSS), etc.


c. Information Based on Incident, Accident, and Near-Miss Reports

* Profession/Job title of the staff involved
* Years of experience
* Department/Affiliation
* Incident level/severity
* Date of occurrence
* Fall risk assessment
* Dementia independence level
* Type of incident
* Cause of incident
* Description/Circumstances of the incident
* Response of the patient and family
* Preventive measures and guidance provided, etc.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

120 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients admitted to the recovery rehabilitation ward between April 1, 2020, and March 31, 2030

Key exclusion criteria

Nothing in particular

Target sample size

1800


Research contact person

Name of lead principal investigator

1st name Hiroaki
Middle name
Last name Sakurai

Organization

Fujita Health University

Division name

School of Health Sciences, Faculty of Rehabilitation

Zip code

470-1192

Address

1-98, Dengakugakubo Kutsukake-cho, Toyoake-shi Aichi 470-1192, Japan

TEL

0562-93-2000

Email

kenji07n@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Kenji
Middle name
Last name Kawakami

Organization

Kitaoji Hospital for Neurological Rehabilitation

Division name

Department of Rehabilitation

Zip code

6068171

Address

25-2 Ichijoji Nishimizuhiki-cho, Sakyo-ku, Kyoto-shi.

TEL

0757815111

Homepage URL


Email

kenji07n@fujita-hu.ac.jp


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

nothing

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fujita Health University Research Support Division

Address

1-98, Dengakugakubo Kutsukake-cho, Toyoake-shi Aichi 470-1192, Japan

Tel

0562-93-2865

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

脳神経リハビリ北大路病院


Other administrative information

Date of disclosure of the study information

2025 Year 09 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2020 Year 04 Month 01 Day

Date of IRB

2025 Year 09 Month 05 Day

Anticipated trial start date

2020 Year 04 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This study is a retrospective cohort study.


Management information

Registered date

2025 Year 09 Month 08 Day

Last modified on

2025 Year 09 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067511